These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7692314)

  • 21. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
    Gubertini G; Scorza D; Beccari M; Buccianti G; Costantino A; Spotti D; Graziani G
    Nephron; 1992; 61(3):271-2. PubMed ID: 1323769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden.
    Mattsson L; Aberg B; von Sydow M; Weiland O
    Scand J Infect Dis; 1991; 23(1):25-9. PubMed ID: 1851323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late seroconversion of C virus markers in hemodialysis patients.
    Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
    Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies.
    Vasile A; Allegra V; Canciani D; Forchì G; Mengozzi G
    Nephron; 1992; 61(3):318-9. PubMed ID: 1323779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus antibody response in acute and chronic non-A, non-B hepatitis.
    Tagger A; Ribero ML; Grossi A; Chiaramonte S; Bortolotti F; Tremolada F
    Nephron; 1992; 61(3):258-9. PubMed ID: 1323766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.
    Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O
    Infection; 1991; 19(5):309-12. PubMed ID: 1666063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays.
    Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F
    Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatitis C virus in dialysis units.
    Gilli P; Soffritti S; De Paoli Vitali E; Bedani PL
    Nephron; 1995; 70(3):301-6. PubMed ID: 7477617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HCV in post-transfusion hepatitis: deductions from a prospective study.
    Feinman SV; Berris B; Herst R
    J Hepatol; 1991 May; 12(3):377-81. PubMed ID: 1658122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV infection in hemodialyzed patients: incidence and correlation with dialytic age.
    Giammaria U; De Meo F; Acitelli S; Tancredi M; Daniele M; Barnabei R; Maschio C
    Nephron; 1992; 61(3):335-6. PubMed ID: 1323783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis C virus (HCV) antibodies in haemodialysis patients.
    Vandelli L; Medici G; Savazzi AM; De Palma M; Lusvarghi E
    Arch Virol Suppl; 1992; 4():339-42. PubMed ID: 1333330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
    Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
    Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients.
    Mondelli MU; Smedile V; Piazza V; Villa G; Barbieri C; Gattarello G; Mancini F; Raimondo G
    Nephrol Dial Transplant; 1991; 6(7):480-3. PubMed ID: 1717892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.